Randomized, Double Blind, Controlled Phase II Trial of the Safety, Tolerability and Immunogenicity of Fluzone Inactivated Trivalent Influenza Virus Vaccine Administered With and Without JVRS-100 Adjuvant in Subjects 65 Years and Older.
Phase of Trial: Phase II
Latest Information Update: 11 Feb 2011
At a glance
- Drugs Influenza virus vaccine; JVRS 100
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Juvaris BioTherapeutics
- 11 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Jan 2010 The trial is expected to be completed in mid-2010, according to a Juvaris BioTherapeutics media release.